AEterna Zentaris (AEZS)
(Delayed Data from NSDQ)
$1.96 USD
0.00 (-0.19%)
Updated Apr 26, 2024 01:33 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for AEterna Zentaris Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 5 | 6 | 5 | 4 | 1 |
Cost Of Goods | 0 | 0 | 0 | 2 | 0 |
Gross Profit | 4 | 5 | 5 | 1 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 22 | 21 | 14 | 7 | 10 |
Income After Depreciation & Amortization | -18 | -15 | -9 | -6 | -10 |
Non-Operating Income | 1 | -7 | 0 | 1 | 4 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -17 | -23 | -8 | -5 | -6 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -17 | -23 | -8 | -5 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -17 | -23 | -8 | -5 | -6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -19 | -17 | -10 | -4 | -10 |
Depreciation & Amortization (Cash Flow) | -1 | -2 | -2 | 1 | 0 |
Income After Depreciation & Amortization | -18 | -15 | -9 | -6 | -10 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 4.86 | 4.86 | 4.60 | 1.71 | 0.69 |
Diluted EPS Before Non-Recurring Items | -3.41 | -2.96 | -1.75 | -3.00 | -13.25 |
Diluted Net EPS (GAAP) | -3.41 | -4.68 | -1.75 | -3.00 | -8.75 |
Fiscal Year end for AEterna Zentaris Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.12 | 0.00 | 2.25 | 2.13 |
Cost Of Goods | NA | 0.06 | 0.01 | 0.14 | 0.02 |
Gross Profit | NA | 0.07 | -0.01 | 2.11 | 2.11 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.46 | 4.54 | 4.96 | 6.32 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -6.39 | -4.55 | -2.85 | -4.21 |
Non-Operating Income | NA | 0.78 | 0.41 | 0.34 | -0.05 |
Interest Expense | NA | 0.01 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -5.63 | -4.15 | -2.52 | -4.26 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.63 | -4.15 | -2.52 | -4.26 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.63 | -4.15 | -2.52 | -4.26 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 4.86 | 4.86 | 4.86 | 4.86 |
Diluted EPS Before Non-Recurring Items | NA | -1.16 | -0.85 | -0.52 | -0.88 |
Diluted Net EPS (GAAP) | NA | -1.16 | -0.85 | -0.52 | -0.88 |